CCR4 and adult T-cell leukemia/lymphoma: ATLL is highly chemotherapy-resistant, and while many current therapies (e.g., antivirals AZT/IFN-α, proteasome inhibitors, anti-CCR4 monoclonal antibody) improve ATLL patient survival (reviewed in [8]), the patients consistently relapse.